Details view: 08. Pharmaceuticals

Views
Add
Edit
- Edit page
- Delete page
Share
Login
- Member login
- Register now for a free account
🔎

08. Pharmaceuticals How1 #366177
*Cost-effective interventions to reduce obesity in the UK*

CONTEXT(Help)

Obesity – Stakeholders »Obesity – StakeholdersObesity – Stakeholders☜Mapping the key stakeholders in the obesity policy sphere – and the actions the contributions they can each make to tackling the obesity crisis in the UK.☜F1CEB7

▲

Stakeholders – Institutions »Stakeholders – InstitutionsStakeholders – Institutions☜This list is growing organically as the project develops, and you are welcome to suggest (and/or add directly) new Stakeholders to the list and to Cite the key reports and positions published and held by your own and/or other stakeholder groups.☜D3ABAB

▲

McKinsey Global Institute »McKinsey Global InstituteMcKinsey Global Institute☜The MGI discussion paper, Overcoming obesity: An initial economic analysis studied studied 74 interventions (in 18 areas) that are being discussed or piloted somewhere around the world to address obesity, including subsidized school meals for all, calorie and nutrition labeling, restrictions on advertising high-calorie food and drinks, and public-health campaigns – with sufficient data found on 44 of the interventions in 16 areas. ☜D3ABAB

▲

Obesity Interventions identified by MGI »Obesity Interventions identified by MGIObesity Interventions identified by MGI☜74 interventions – across 18 groups – to reduce obesity.☜5CA4D9

■

08. Pharmaceuticals08. Pharmaceuticals☜☜5CA4D9

●

Over-the-counter pharmaceuticals »Over-the-counter pharmaceuticalsOver-the-counter pharmaceuticals☜Provision of non-prescription weight-loss drugs.☜5CA4D9

●

Prescription pharmaceuticals »Prescription pharmaceuticalsPrescription pharmaceuticals☜Medical prescription of weight-loss drugs.☜5CA4D9

►

Develop better pharmaceutical obesity therapies »Develop better pharmaceutical obesity therapiesDevelop better pharmaceutical obesity therapies☜Obesity drug sales are forecast to $3.8bn globally in 2018 [2]—in comparison to $57bn for Diabetes drug sales[2]—with evidence suggesting that the modest average weight losses achieved with current anti-obesity agents may be of some clinical benefit [5]. However, the current generation of drugs, which act on the central nervous system to suppress appetite, have raised significant health concerns—including psychiatric disorders, such as suicidal behaviour, depression, and cardiovascular problems.☜FFFACD

Heading

Summary

Click the button to enter task scheduling information

Details

Enter task details

Message text

Select assignee(s)

Due date (click calendar)

RadDatePicker

Open the calendar popup.

Calendar

Title and navigation
Title and navigation
<<	<	November 2024	>	<<

November 2024
	S	M	T	W	T	F	S
44	27	28	29	30	31	1	2
45	3	4	5	6	7	8	9
46	10	11	12	13	14	15	16
47	17	18	19	20	21	22	23
48	24	25	26	27	28	29	30
49	1	2	3	4	5	6	7

Reminder

Ready to post Copy to text

Task assignment(s) have been emailed and cannot now be altered

Lock

Comment graphing options

Choose comments:Comment onlyWhole threadAll comments

Choose location:To a new mapTo this map

New map options

Select map ontology Graph to private map

+Comments (0)

- CommentsAdd a commentNewest firstOldest firstShow threads

+Citations (0)

- CitationsAdd new citationList by: CiterankMap

+About

- About

Entered by:- David Price
NodeID: #366177
Node type: How
Entry date (GMT): 11/23/2014 4:37:00 PM
Last edit date (GMT): 11/23/2014 8:38:00 PM
Show other editors
Incoming cross-relations: 0
Outgoing cross-relations: 1
Average rating: 4 by 1 users

x Select file to upload